Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1993 1
1995 1
1996 3
1997 3
1998 3
1999 1
2000 2
2001 8
2002 7
2003 4
2004 6
2005 9
2006 2
2007 9
2008 10
2009 6
2010 3
2011 8
2012 3
2013 9
2014 11
2015 14
2016 13
2017 12
2018 22
2019 21
2020 28
2021 36
2022 42
2023 49
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

313 results

Results by year

Filters applied: . Clear all
Page 1
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study.
Shah BD, Ghobadi A, Oluwole OO, Logan AC, Boissel N, Cassaday RD, Leguay T, Bishop MR, Topp MS, Tzachanis D, O'Dwyer KM, Arellano ML, Lin Y, Baer MR, Schiller GJ, Park JH, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff P, Jeyakumar D, Feng C, Dong J, Shen T, Milletti F, Rossi JM, Vezan R, Masouleh BK, Houot R. Shah BD, et al. Lancet. 2021 Aug 7;398(10299):491-502. doi: 10.1016/S0140-6736(21)01222-8. Epub 2021 Jun 4. Lancet. 2021. PMID: 34097852 Clinical Trial.
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.
Wei AH, Döhner H, Pocock C, Montesinos P, Afanasyev B, Dombret H, Ravandi F, Sayar H, Jang JH, Porkka K, Selleslag D, Sandhu I, Turgut M, Giai V, Ofran Y, Kizil Çakar M, Botelho de Sousa A, Rybka J, Frairia C, Borin L, Beltrami G, Čermák J, Ossenkoppele GJ, La Torre I, Skikne B, Kumar K, Dong Q, Beach CL, Roboz GJ; QUAZAR AML-001 Trial Investigators. Wei AH, et al. N Engl J Med. 2020 Dec 24;383(26):2526-2537. doi: 10.1056/NEJMoa2004444. N Engl J Med. 2020. PMID: 33369355 Clinical Trial.
Authors' Reply.
Robinson CH, Jeyakumar N, Wald R, Zappitelli M, Chanchlani R. Robinson CH, et al. J Am Soc Nephrol. 2021 Oct;32(10):2681-2682. doi: 10.1681/ASN.2021060879. Epub 2021 Sep 16. J Am Soc Nephrol. 2021. PMID: 34531178 Free PMC article. No abstract available.
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study.
Sallman DA, Al Malki MM, Asch AS, Wang ES, Jurcic JG, Bradley TJ, Flinn IW, Pollyea DA, Kambhampati S, Tanaka TN, Zeidner JF, Garcia-Manero G, Jeyakumar D, Komrokji R, Lancet J, Kantarjian HM, Gu L, Zhang Y, Tan A, Chao M, O'Hear C, Ramsingh G, Lal I, Vyas P, Daver NG. Sallman DA, et al. J Clin Oncol. 2023 May 20;41(15):2815-2826. doi: 10.1200/JCO.22.01794. Epub 2023 Mar 8. J Clin Oncol. 2023. PMID: 36888930 Clinical Trial.
Comments on "Structural, optical and electrical properties of Zr-doped In(2)O(3) thin films" by C. Manoharan, M. Jothibas, S. Johnson Jeyakumar, S. Dhanapandian published in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 145 (2015) 47-53.
Tomaszewski PE. Tomaszewski PE. Spectrochim Acta A Mol Biomol Spectrosc. 2018 Nov 5;204:640. doi: 10.1016/j.saa.2018.06.090. Epub 2018 Jun 28. Spectrochim Acta A Mol Biomol Spectrosc. 2018. PMID: 29982153 No abstract available.
Use of Cholinesterase Inhibitors in Non-Alzheimer's Dementias.
Noufi P, Khoury R, Jeyakumar S, Grossberg GT. Noufi P, et al. Drugs Aging. 2019 Aug;36(8):719-731. doi: 10.1007/s40266-019-00685-6. Drugs Aging. 2019. PMID: 31201687 Review.
Non-Alzheimer's dementias constitute 30% of all dementias and present with major cognitive and behavioral disturbances. Cholinesterase inhibitors improve memory by increasing brain acetylcholine levels and are approved symptomatic therapies for Alzheimer's disease ( …
Non-Alzheimer's dementias constitute 30% of all dementias and present with major cognitive and behavioral disturbances. Cholinesteras …
313 results